Co-incubation of pancreatic cancer cells with IFN-β and TGZ suppresses STAT3 activation and delays G0/G1-S phase progression that occurred together with an increase in p21 and p27 protein expression that was more evident after 24 hours of treatment with the pharmacological combination. The gene discussed is IFNB1; the disease is pancreatic neoplasm.